Loading chat...
CT HB07023
Bill
Status
Passed
7/11/2017
Primary Sponsor
Insurance and Real Estate Committee
Click for details
AI Summary
- Prohibits step therapy requirements lasting longer than 60 days for any prescribed drug covered under individual and group health insurance policies
- Eliminates step therapy requirements entirely for cancer treatment drugs prescribed to patients diagnosed with stage IV metastatic cancer, provided the drugs comply with FDA-approved indications
- Allows a treating health care provider to deem a step therapy drug regimen clinically ineffective after the applicable time period expires, requiring insurers to authorize coverage for the provider's prescribed alternative drug
- Applies to insurance companies, hospital service corporations, medical service corporations, health care centers, and other entities delivering health insurance with prescription drug coverage
- Takes effect January 1, 2018
Legislative Description
An Act Concerning Step Therapy For Prescription Drugs Prescribed To Treat Stage Iv Metastatic Cancer.
Last Action
Signed by the Governor
7/11/2017
Committee Referrals
Insurance and Real Estate2/8/2017
Full Bill Text
No bill text available